18 results with keyword: 'igg antibody response to polyethylene glycol modified adenosine deaminase in patients with adenosine deaminase deficiency'
Based on the present and ongoing studies, we recommend monitor- ing of preinjection plasma ADA levels every other week during the first six to eight months of therapy with PEG-ADA,
N/A
Functional reconstitution was marked by the successive appearance of mitogen responses dependent on exogenous in vitro IL-2, mitogen responses not requiring exogenous
N/A
In patients with mild, moderate or severe renal insufficiency and in patients with mild to moderate hepatic insufficiency treated with daily doses of 20 mg
N/A
Keywords: adenosine deaminase, severe combined immunodeficiency, gene therapy, hema- topoietic stem cell, retrovirus, clinical trial.. Adenosine
N/A
Polyethylene glycol– conjugated adeno- sine deaminase (PEG-ADA) provides an alternate ther- apy to mismatched stem cell transplantation for patients with ADA-deficient severe
N/A
A Study on the Serum Adenosine Deaminase Activity in Patients with Typhoid Fever and Other Febrile Illnesses.. Key Words: Adenosine deaminase (ADA), Typhoid fever, Cell
N/A
ADA: Adenosine deaminase; ATP: Adenosine triphosphate; dATP: Deoxyadenosine triphosphate; ERT: Enzyme replacement therapy; GT: Gene therapy; HSCT: Haematopoietic stem
N/A
SEVERE COMBINED IMMUNODEFICIENCY, (AUTOSOMAL RECESSIVE), T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL- NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY, SCID. ADA (ADENOSINE
N/A
Quantitative analysis of the survey data aimed to investigate the relationship between MOI and the strength of national identity showed that Kazakh-educated students had
N/A
DATA SII0WING DIETARY CA:P RATIO AND CONCENTRATION OF P IN HUMAN MILK AND IN FORMULAS USED IN 16 CASES OF NEONATAL TETANY..
N/A
ADA messenger RNAs and their translation products have been characterized in seven human lymphoblast cell lines derived as follows: GM- 130, GM-131, and GM-2184 from normal
N/A
With the development of polyethylene glycol–conjugated adenosine deaminase (PEG-ADA) enzyme replacement therapy, many ADA-deficient children with SCID who could not receive
N/A
Keywords: adenosine deaminase deficiency, PEG-ADA, enzyme replacement therapy, severe combined immune deficiency
N/A
Severe Combined Immunodeficiency IL-2 receptor gamma chain deficiency Adenosine deaminase deficiency.. Purine nucleoside
N/A
Role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in children. Cerebrospinal fluid adenosine deaminase: its
N/A
(A) SAC-arrested HeLa cells depleted of individual PP2A-B56 sub- units were treated with MG132 alone or a combination of MG132 and Mps1 inhibitor AZ3146 for 5 min, fixed, and
N/A
Abbreviations: ADA: adenosine deaminase; ADO: adenosine; ADORA1: adenosine receptor A1; ADORA2A: adenosine receptor A2A; ADORA2B: adenosine receptor A2B; ADORA3: adenosine receptor
N/A
We now report that lym- phoid cells from one of these two previously studied partially ADA-deficient patients contain an enzyme with a more basic isoelectric point, while lymphoid
N/A